0 Ratings

ID

43958

Description

A Study of IL-12 in Patients With Acute Myelogenous Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT02483312

Link

https://clinicaltrials.gov/show/NCT02483312

Keywords

  1. 4/1/16 4/1/16 -
  2. 9/20/21 9/20/21 -
Uploaded on

September 20, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Acute Myeloid Leukemia NCT02483312

    Eligibility Acute Myeloid Leukemia NCT02483312

    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    patient with aml and >=18 years of age.
    Description

    AML

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0023467
    Patient agrees to participate in the study and signs the informed consent
    Description

    Informed Consent

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    viably frozen cells from the time of diagnosis or relapse are available
    Description

    Peripheral blood mononuclear cell

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1321301
    first complete remission and have high risk features of relapse.
    Description

    In complete remission

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0677874
    less than 10% blast cells in the bone marrow following induction or re-induction therapy and not desiring further intensive treatment.
    Description

    Blast Cell

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0368761
    acceptable creatinine, ast, alp, bilirubin
    Description

    Creatinine

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0010294
    agree to use contraception
    Description

    Contraceptive methods

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0700589
    not pregnant
    Description

    Not pregnant

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0232973
    able to comply with study procedures
    Description

    comply with study procedures

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0525058
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    ecog performance status <2
    Description

    ECOG performance status

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    known persistent infection
    Description

    Persistent infection

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1264606
    known cns disease
    Description

    cns disease

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0007682
    greater than 10% blasts in the bone marrow or circulating blast cells
    Description

    Blast Cell

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0368761
    life expectancy < 2 months
    Description

    Life Expectancy

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0023671
    receiving any chemotherapy, corticosteroids, cox2 inhibitors or any non-drug therapies with the intent of altering the immune response or kill leukemic cells within one week prior to infusion of il-12 -infected cells.
    Description

    Leukemic Cells

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0020964
    UMLS CUI [2]
    C3890400

    Similar models

    Eligibility Acute Myeloid Leukemia NCT02483312

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    AML
    Item
    patient with aml and >=18 years of age.
    boolean
    C0023467 (UMLS CUI [1])
    Informed Consent
    Item
    Patient agrees to participate in the study and signs the informed consent
    boolean
    C0021430 (UMLS CUI [1])
    Peripheral blood mononuclear cell
    Item
    viably frozen cells from the time of diagnosis or relapse are available
    boolean
    C1321301 (UMLS CUI [1])
    In complete remission
    Item
    first complete remission and have high risk features of relapse.
    boolean
    C0677874 (UMLS CUI [1])
    Blast Cell
    Item
    less than 10% blast cells in the bone marrow following induction or re-induction therapy and not desiring further intensive treatment.
    boolean
    C0368761 (UMLS CUI [1])
    Creatinine
    Item
    acceptable creatinine, ast, alp, bilirubin
    boolean
    C0010294 (UMLS CUI [1])
    Contraceptive methods
    Item
    agree to use contraception
    boolean
    C0700589 (UMLS CUI [1])
    Not pregnant
    Item
    not pregnant
    boolean
    C0232973 (UMLS CUI [1])
    comply with study procedures
    Item
    able to comply with study procedures
    boolean
    C0525058 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    ECOG performance status
    Item
    ecog performance status <2
    boolean
    C1520224 (UMLS CUI [1])
    Persistent infection
    Item
    known persistent infection
    boolean
    C1264606 (UMLS CUI [1])
    cns disease
    Item
    known cns disease
    boolean
    C0007682 (UMLS CUI [1])
    Blast Cell
    Item
    greater than 10% blasts in the bone marrow or circulating blast cells
    boolean
    C0368761 (UMLS CUI [1])
    Life Expectancy
    Item
    life expectancy < 2 months
    boolean
    C0023671 (UMLS CUI [1])
    Leukemic Cells
    Item
    receiving any chemotherapy, corticosteroids, cox2 inhibitors or any non-drug therapies with the intent of altering the immune response or kill leukemic cells within one week prior to infusion of il-12 -infected cells.
    boolean
    C0020964 (UMLS CUI [1])
    C3890400 (UMLS CUI [2])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial